ASSOCIATION OF MIR29 RNA WITH RESPONSE AND SURVIVAL IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH AZACITIDINE (AZA) OR CONVENTIONAL CARE REGIMENS (CCR)

被引：0
|
作者：
MacBeth, K. J. [1 ]
Tang, L. [1 ]
Seymour, J. F. [2 ]
Stone, R. M. [3 ]
Minden, M. D. [4 ]
Lucy, L. M. [1 ]
Beach, C. [1 ]
Doehner, H. [5 ]
机构：
[1] Celgene Corp, Summit, NJ USA
[2] Peter MacCallum Canc Ctr, East Melbourne, Australia
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Univ Ulm Klinikum, Ulm, Germany
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S797
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [1] Impact of Gene Mutations on Overall Survival in Older Patients with Acute Myeloid Leukemia (AML) Treated with Azacitidine (AZA) or Conventional Care Regimens (CCR)
    Tang, Lin
    Dolnik, Anna
    MacBeth, Kyle J.
    Dombret, Herve
    Seymour, John F.
    Minden, Mark D.
    Stone, Richard M.
    Beach, C. L.
    Dohner, Hartmut
    Bullinger, Lars
    BLOOD, 2016, 128 (22)
  • [2] Azacitidine (AZA) Prolongs Overall Survival in Older Patients with Acute Myeloid Leukemia (AML) with Poor Prognostic Karyotypes Compared with Conventional Care Regimens (CCR)
    Doehner, Hartmut
    Vyas, Paresh
    Seymour, John F.
    Santini, Valeria
    Stone, Richard M.
    Minden, Mark D.
    Al-Ali, Haifa Kathrin
    Del Castillo, Teresa Bernal
    Morrill, John
    Songer, Stephen
    Weaver, Jerry
    Skikne, Barry S.
    Beach, C. L.
    Dombret, Herve
    BLOOD, 2016, 128 (22)
  • [3] IMPACT OF GENE MUTATIONS ON SURVIVAL WITH AZACITIDINE OR CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Tang, L.
    Dolnik, A.
    MacBeth, K. J.
    Dombret, H.
    Seymour, J. F.
    Minden, M. D.
    Stone, R. M.
    Beach, C. L.
    Doehner, H.
    Bullinger, L.
    LEUKEMIA RESEARCH, 2017, 55 : S69 - S70
  • [4] OVERALL SURVIVAL (OS) WITHOUT COMPLETE REMISSION (CR) IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): AZACITIDINE (AZA) VS CONVENTIONAL CARE REGIMENS (CCR) IN THE AZA-AML-001 STUDY
    Schuh, A.
    Dombret, H.
    Sandhu, I.
    Seymour, J. F.
    Stone, R. M.
    Al-Ali, H. K.
    Alimena, G.
    Lewis, I.
    Kyun, S. Sang
    Geddes, M.
    Cilloni, D.
    Je-Hwan, L.
    Songer, S.
    Lucy, L. M.
    Beach, C.
    Doehner, H.
    HAEMATOLOGICA, 2015, 100 : 219 - 220
  • [5] AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN ELDERLY PATIENTS (≥75 YEARS) WITH ACUTE MYELOID LEUKEMIA (AML) IN THE AZA-AML-001 STUDY
    Seymour, J. F.
    Buckstein, R.
    Santini, V.
    Doehner, H.
    Stone, R. M.
    Minden, M. D.
    Kuo, C. Y.
    Ben-Yehuda, D.
    Bargay, J.
    Songer, S.
    Weaver, J.
    Beach, C. L.
    Dombret, H.
    LEUKEMIA RESEARCH, 2017, 55 : S67 - S68
  • [6] Efficacy and Safety of Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Patients Aged ≥75 Years with Acute Myeloid Leukemia (AML) in the Phase 3 AZA-AML-001 Study
    Seymour, John F.
    Buckstein, Rena
    Santini, Valeria
    Doehner, Hartmut
    Stone, Richard M.
    Minden, Mark D.
    Kuo, Ching-Yuan
    Ben-Yehuda, Dina
    Bargay, Joan
    Songer, Stephen
    Weaver, Jerry
    Beach, C. L.
    Dombret, Herve
    BLOOD, 2016, 128 (22)
  • [7] AZACITIDINE (AZA) VS CONVENTIONAL CARE REGIMENS (CCR) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WITH MYELODYSPLASIA-RELATED CHANGES (MRC) IN AZA-AML-001 PER CENTRAL REVIEW
    Seymour, J. F.
    Doehner, H.
    Schuh, A. C.
    Stone, R. M.
    Minden, M.
    Weaver, J.
    Songer, S.
    Beach, C.
    Dombret, H.
    HAEMATOLOGICA, 2016, 101 : 218 - 219
  • [8] RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF AZACITIDINE (AZA) VS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
    Dombret, H.
    Seymour, J. F.
    Butrym, A.
    Wierzbowska, A.
    Selleslag, D.
    Jang, J. H.
    Kumar, R.
    Cavenagh, J.
    Schuh, A.
    Candoni, A.
    Recher, C.
    Sandhu, I.
    Bernal, T.
    Al-Ali, H. K.
    Martinelli, G.
    Stone, R. M.
    Minden, M. D.
    McIntyre, H.
    Songer, S.
    Lucy, L.
    Beach, C.
    Doehner, H.
    HAEMATOLOGICA, 2014, 99 : 788 - 789
  • [9] Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care
    Doehner, Hartmut
    Dolnik, Anna
    Tang, Lin
    Seymour, John F.
    Minden, Mark D.
    Stone, Richard M.
    Bernal del Castillo, Teresa
    Al-Ali, Haifa Kathrin
    Santini, Valeria
    Vyas, Paresh
    Beach, C. L.
    MacBeth, Kyle J.
    Skikne, Barry S.
    Songer, Steve
    Tu, Nora
    Bullinger, Lars
    Dombret, Herve
    LEUKEMIA, 2018, 32 (12) : 2546 - 2557
  • [10] Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care
    Hartmut Döhner
    Anna Dolnik
    Lin Tang
    John F. Seymour
    Mark D. Minden
    Richard M. Stone
    Teresa Bernal del Castillo
    Haifa Kathrin Al-Ali
    Valeria Santini
    Paresh Vyas
    C. L. Beach
    Kyle J. MacBeth
    Barry S. Skikne
    Steve Songer
    Nora Tu
    Lars Bullinger
    Hervé Dombret
    Leukemia, 2018, 32 : 2546 - 2557
12345